| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cardinal Health Inc (CAH) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. CAH is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 200.0K | $44.35M | - | |
| Dir | 64.2K | $14.24M | - | |
| CEO | 52.9K | $11.73M | - | |
| CFO | 44.4K | $9.86M | - | |
| Other | 34.4K | $7.63M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2024 | Mayer Jessica L | Chief Legal/ Compliance Officer | Sell | 16,573 | $109.39 | $1,812,920.47 | -17.9% | +7.9% | +38.2% | |
| Aug 19, 2024 | Alt Aaron E | Chief Financial Officer | Sell | 2,323 | $108.91 | $252,997.93 | -5.9% | +9.3% | +35.7% | |
| Aug 19, 2024 | Snow Ola M45 | Chief Human Resources Officer | Sale+OE | 37,941 | $108.91 | $4,132,275.00 | -34.2% | +9.3% | +35.7% | |
| Aug 19, 2024 | Greene Michelle D. | Chief Information Officer | Sell | 4,000 | $108.85 | $435,400.00 | -17.2% | +9.3% | +35.7% | |
| Aug 19, 2024 | Hollar Jason M. | Chief Executive Officer | Sell | 73,171 | $108.97 | $7,973,095.02 | -14.2% | +9.3% | +35.7% | |
| Aug 19, 2024 | Mason Stephen M | CEO, Gmpd Segment | Sale+OE | 46,998 | $109.21 | $5,132,847.58 | -36.5% | +9.3% | +35.7% | |
| Aug 15, 2024 | Mayer Jessica L | Chief Legal/ Compliance Officer | Sale+OE | 17,896 | $106.48 | $1,905,566.08 | -15.9% | +16.1% | +38.6% | |
| Nov 27, 2023 | Weitzman Deborah | CEO, Pharmaceutical Segment | Sale+OE | 36,642 | $106.31 | $3,895,411.02 | -51.0% | +3.4% | +14.8% | |
| Aug 28, 2023 | Weitzman Deborah | CEO, Pharmaceutical Segment | Sale+OE | 6,712 | $89.81 | $602,804.72 | -13.2% | +18.8% | +22.7% | |
| Aug 18, 2023 | Scherer Mary C. | Chief Accounting Officer | Sale+OE | 20,695 | $86.27 | $1,785,357.65 | -66.0% | +20.3% | +28.0% |